ULMA

ULMA Medical Technologies is a Spain-based healthcare technology company within the ULMA group focused on AI-enabled diagnostics, clinical workflow software, and medical devices. The company’s core offering is the UMI platform, a scalable web-based patient management and diagnostic support system used in ophthalmology and dermatology. Its lead commercial product is UMI DR, a CE-marked artificial intelligence solution for diabetic retinopathy screening, complemented by retinal analysis modules, edge computing devices, and a portable non-mydriatic fundus camera. ULMA Medical Technologies is positioning itself as a digital diagnostics and telemedicine provider rather than a therapeutics developer, with current emphasis on ophthalmology and dermatology and additional ophthalmic programs in development. The company appears to be commercially active in Europe and pursuing broader international deployment of its software and device solutions.